SlideShare una empresa de Scribd logo
1 de 40
Microbial Contamination Control
  in Parenteral Manufacturing


            Pragati Kumar
                Bada
              pragatk@yahoo.com
•Parenteral products are radically different from other
dosage forms in terms of standards of purity and
safety.

•Apart from complying with standards of potency and
stability, parenterals have to meet exacting standards
of microbial (sterility and pyrogens), physical
(particulate         matter),        and        chemical
(isotonicity, buffering capacity, etc.) parameters.
Various layers of protection in a typical Parenteral manufacturing
Terminal Sterilization
•   In 1991 USFDA proposed that all sterile products should
    be terminally sterilized, unless data were available to
    prove its adverse effects on product stability . This was
    primarily due to the fact that all product recalls during
    1981 to 1991 involved aseptically processed products .

•   Certain drug classes, such as biologics, multidose
    ophthalmic products, and dispersed systems, are exempt
    from this.

•   The most commonly used technique for terminal
    sterilization is autoclaving, which makes use of saturated
    steam.

•   Compendial cycles for autoclaving in          USP/EP/BP
    prescribe a 15-minute exposure at 121°C.
The most heat resistant microorganism actually
  contaminating the formulation—or Bacillus
  stearothermophillus because of its high heat
  resistance—is used as a standard microbe for
  development of autoclaving cycles.
New Techniques of Terminal Sterilization:
There is a strong need to develop terminal
sterilization techniques that can help in
achieving acceptable Sterility assurance level
without causing damage to the product.
• PurePulse® Technologies USA has developed
  a technique called Pure Bright sterilization.
• It uses broad-spectrum pulsed light (BSPL) to
  effectively inactivate bacterial organisms and
  spores in static and flowing solutions, as well
  as on dry surfaces.
• BSPL generated from xenon lamps contain
  visible, infrared, and UV wavelengths in ratios
  similar to sunlight.
• The major difference from sunlight is that the
  UV wavelengths are removed due to filtration
  by Earth’s atmosphere.
• Rapid intense pulses of BSPL are used for
  inactivation of pathogens.
ASEPTIC PROCESSING
•  Aseptic processing involves filling of pre-sterilized
   formulations into cleaned and pre-sterilized primary
   packaging components.
• In absence of any post-filling sterilization step, the SAL
   of finished product is a direct function of SAL of
   individual components.
• Many                aseptically              manufactured
   presentations, especially multi dose products, contain
   preservatives that serve a dual purpose of
      (a) providing antimicrobial activity and
      (b) preventing proliferation of any microbe that
might            contaminate the product during repeated
use.
• Sterility assurance levels for aseptic processing is
   determined by performing media fill trials
Sources of Contamination and Control Strategy
                During Aseptic Manufacture

Contributing parameter          Control strategy
Environmental air        Passing air supply through High
                         Efficiency Particle Air (HEPA)
                         filters.
                         Laminar air flow (90 feet/min) is
                         used to ―sweep away‖ particles
                         and microbes from the sensitive
                         areas.
                         Environmental air Pressure
                         differentials to protect areas of
                         critical operations.
Contributing parameter             Control strategy
Manufacturing            •   For fixed equipment Vacuum
                             cleaner equipped with HEPA
equipment                    filtered exhaust.

                         •   Wet wiping with disinfectant
                             solution for Manufacturing
                             equipment.

                         •   For demountable
                             equipments cleaning and
                             autoclaving should be
                             performed.
Contributing parameter         Control strategy
Formulation and          • Powders for injection are
primary packaging          supplied as sterile by bulk
components
                           drug manufacturers.
                         • Liquid products are filtered
                           through sterile 0.22 μm
                           membrane filters.
                         • Glass vials are cleaned and
                           dry heat sterilized Rubber
                           stoppers are cleaned and
                           sterilized by autoclaving.
Contributing          Control strategy
     parameter
Personnel          •   Medical examination to screen
                       personnel working in aseptic
                       area.
                   •   Entry of personnel to aseptic
                       area should be through
                       changing rooms.
                   •   Containment of personnel
                       microbial flora by protective
                       clothing.
                   •   Localized barriers between
                       personnel and areas of filling
                       operations, by means of
                       laminar airflow or by using
                       isolator barriers.
Contributing          Control strategy
     parameter
Water and          Purification of water by distillation
drainage           or reverse osmosis.

                   Storage of WFI at temperatures
                   >80°C and in vessels fitted with
                   continuous circulation loop.

                   Efficient   drainage     at    the
                   manufacturing shop floor to
                   prevent accumulation of water.
Blow-Fill-Seal Technology (BFS)
BFS technology involves a fully automated process in
which the primary container for the formulation is
(a)formed from a thermoplastic.
(b)Aseptically filled with filtered solution
(c)sealed, in a single operation in a controlled environment.

•   BFS uses an automated process requiring minimal human
    intervention once the machine settings have been set.

•   The formed plastic container is filled with sterile product
    and instantly sealed, thus avoiding contamination.

•   A hermetically sealed bottle formed during the process
    helps avoid the use of sealing devices like rubber closures
    and seals.
Formation of blow-fill-seal pack.
• Various      thermoplastics        like polyethylene
  (PE), polypropylene (PP), various copolymers and
  polyalomers are commercially available.

• PP offers distinct advantages by allowing exposure to
  121°C for autoclaving. Bottles produced on the BFS
  machine can be individual or strip-dose formats, in sizes
  from 0.1 ml to 2000 ml, and outputs as high as 30,000
  units/hour can be achieved.

• BFS technology has offered a cost-effective means of
  Microbial contamination control introducing high-quality
  aseptically processed products with additional advantage
  of reduced breakage, reduced hazard of accidental
  injury, and reduced pack volume over glass containers.
RECENT ISSUES IN STERILIZATION BY FILTRATION

•   Sterilization by filtration has traditionally involved use of
    0.2/0.22 μm rated filters and Pseudomonas diminuta (now
    called Brevundimonas diminuta) as the standard challenge
    organism.

•   USFDA defines minimum qualifying area of 107/cm2 of filter
    area.

•   Stressful conditions may affect the changes in the
    morphology of the microbes.

•   In this study,40% reduction in size of Burkholderia pickettii
    was observed.

•   These developments are causing a shift from 0.2/0.22
    rated filters to 0.1micron filters.
STERILE PREFILLED SYRINGES (PFS)
• PFS have become a popular packaging system for
  parenteral products due to their advantages of ease of
  administration, dosing accuracy, and increased assurance
  of sterility. PFS consists of a barrel, a plunger rod with
  rubber fitting, and a luer-lock tip/stainless steel needle.
• The manufacturing process for PFS may involve (a) filling
  of formulation in previously cleaned and sterilized PFS or
  (b) cleaning, sterilization, de-pyrogenation of non sterile
  syringes, followed by filling .
• The filling is carried out in Class 100 area, and other
  operations can be carried out in Class 10,000/100,000
  area.
• Terminal sterilization of PFS by autoclaving poses a
  unique challenge due to the possibility of rubber plunger
  migration during the process. This ―pop-off‖ of rubber
  plunger can be prevented by using autoclaves with a
  counter-pressure feature.
PROCESS VALIDATION, HAZARD ANALYSIS AND CRITICAL
                  CONTROL POINTS (HACCP)


HACCP involves seven principles:
(a)analyzing each step for hazard.
(b)Identifying all critical control points (CCP).
(c)verifying the limit for each CCP.
(d) verifying monitoring and testing of limits.
(e)verifying corrective actions.
(f)verifying operational procedures for CCPs, and
(g)verifying that records of each CCP are
   documented in the batch record.
Critical Control Points in a Typical Parenteral Product Manufacturing
Test Organism
The selection of a biological indicator appropriate for
use with a particular sterilization process requires
the consideration of a number of factors.

First is identification of the appropriate test
organism. The test organisms indicated in Table 1
are generally recognized to exhibit greater
resistance to the indicated sterilization processes
than typical bioburden.
An example of different biological indicator formats,
including spore suspensions, inoculated carriers, paper strip
biological indicators, and self-contained biological
indicators.
Suspensions and Inoculated Carriers : Aliquots of the
test organism are either inoculated directly onto
product or onto suitable carriers that are then placed in
those locations of the product considered to be the
most difficult to sterilize.
Following sterilization processing the number of
surviving test organisms is determined by either direct
transfer to growth medium (fraction-negative analysis)
or removal of the test organisms from the product or
carrier for direct enumeration.
Paper Strip Biological Indicators : This type of
biological indicator, consisting of a paper strip carrier
inoculated with a suspension of test organisms and
packaged in a glassine or Tyvek outer envelope has
seen little change since its commercialization during
Self-Contained Biological Indicators : Self-contained
biological indicators are widely used in many
applications, as they do not require the user to
aseptically transfer the inoculated carrier to growth
medium.
Self-contained biological indicators incorporate both
the test organisms and the growth medium within the
same unit and are typically of two distinct types.
The simplest form of self-contained biological
indicators consist of a hermetically sealed glass
ampule or vial containing spores of Geobacillus
stearothermophilus suspended in growth medium with
a pH indicator dye. Following sterilization processing
the ampule is incubated and growth of the test
organisms detected as a change in the color of the
WATER MICROBIOLOGY
PRE TREATMENTS OF WATER
•   The        principal    purification   units   of
    distillation,      reverse       osmosis,    ion-
    exchange, and electrodeionization can purify at
    least some small quantity of water of any
    degree of contamination even without
    pretreatment.

•   The question is how much before the particular
    purification unit is fouled or possibly irreparably
    damaged.

•   Chlorine will rapidly and irreversibly degrade
    polyamide RO membranes. Chloride ions will
    cause the corrosion of stainless steels.
Chlorination
•   As a first step, raw waters are commonly
    chlorinated to kill pathogenic microbes. Chlorine
    concentrations of 1 ppm effect a 97% kill of E. coli
    in 0.6 minutes at 5–25°C, and 0.5 ppm amounts
    have the same effect in 7 minues at 5°C.
    Salmonella and Cholera are killed by 3 ppm.

•   When chlorine contacts water it reacts to form
    hypochlorous acid. HOCl dissociates to yield
    hydrogen ions, H+ (or hydronium ions, H3O+), and
    hypochlorous ions, OCl−. The sum of the
    hypochlorous acid and the hypochlorite ions is
    called the ―free available chlorine.‖ Hypochlorous
    acid is about 100 times stronger in its oxidizing
    potential than is the hypochlorite ion.
chlorine partakes oxidatively in a free radical
chain reaction with TOC present in the water to
form the carcinogenic trihalomethanes (THM).
                 REMOVAL OF THM
The trihalomethanes found in feed waters consist of
mixtures of chlorine and bromine atoms substituent on the
single carbons created by the free radical chain scission
reaction of chlorine on longer carbon-to-carbon TOC
chains.

Monobromo,           dichloromethane             Br-CH-Cl2;
monochloro, dibromomethane Cl-CH-Br2; bromoform HC-
Br3; and chloroform HC-Cl3 constitute the trihalomethanes.

The THMs, except for chloroform, are destroyed to an
85% extent by 185 nm UV.
They are removed by reaction with anion exchange
resin in hydroxyl form; chloroform only to the extent of
50%. They are adsorbed by activated carbon in
proportion to the surface area of the carbon and
increasingly with bromine content; chloroform CHCl3
10%, bromoform CHBr3 50%.
Deep Beds and Multimedia Filtration
•   Multimedia bed design is versatile, but there is no
    ready way to match its available constructions to
    the TSS, to the total suspended solids contents of
    given waters.

•   Particles too small in size to be retained even by
    the (bottom) most finely ground, densest medium
    bed may be present, as also colloidal particles.

•   Coagulation and flocculation techniques are then
    invoked to agglomerate the ultrafine particles to
    sizes that can be removed by the deep beds.
Cross sections of representative filter particle gradations.

Diagram (a) represents a single medium bed such as a rapid sand
filter.
The bottom half of a filter of this type does little or no work.
Diagram (b) represents an ideal filter uniformly graded from coarse to
fine from top to bottom.
Diagram (c) represents a dual media bed, with coarse coal above fine
sand, which approaches the goal of the ideal filter.
Softening and Solubility Product
Water softening is usually accomplished by way
of sodium-form ion-exchange wherein the ion-
exchange resin in the softening unit removes the
hardness-causing elements from the feed waters
by exchanging them for the sodium ions it
releases.

This fore-stalls subsequent mineral fouling of the
RO by membrane-blocking deposits of alkaline
earth salts of limited solubilities, such as the
sulfates,    carbonates,    and     fluorides   of
calcium, barium, or strontium.
The solubility product of a salt is the maximum product of its cation and anion
concentration expressed in moles per liter that can exist in equilibrium with its
undissolved phase at any one temperature.

Más contenido relacionado

La actualidad más candente

Qualification of Tablet Compression Machine.pptx
Qualification of Tablet Compression Machine.pptxQualification of Tablet Compression Machine.pptx
Qualification of Tablet Compression Machine.pptxDhruvi50
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validationSagar Savale
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyroshankhetade2
 
Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.Nitin Dabhade
 
Sterile Facilities
Sterile FacilitiesSterile Facilities
Sterile FacilitiesEric Sipe
 
USP <1116> and its impact on Microbiology
USP <1116> and its impact on MicrobiologyUSP <1116> and its impact on Microbiology
USP <1116> and its impact on MicrobiologyTim Sandle, Ph.D.
 
Environmental monitoring - viable particle sampling
Environmental monitoring - viable particle samplingEnvironmental monitoring - viable particle sampling
Environmental monitoring - viable particle samplingJerry Fahrni
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operationTim Sandle, Ph.D.
 
STERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATIONSTERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATIONSagar Savale
 
Aseptic process tech & advanced sterile product mfg rashmi nasare
Aseptic process tech & advanced sterile product mfg  rashmi nasareAseptic process tech & advanced sterile product mfg  rashmi nasare
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
 
Improved Tablet Production.pptx
Improved Tablet Production.pptxImproved Tablet Production.pptx
Improved Tablet Production.pptxShwetaSonawane23
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processingdeepakiitbhu
 
cleaning validation for SSP.pptx
cleaning validation for SSP.pptxcleaning validation for SSP.pptx
cleaning validation for SSP.pptxSurafelKebede5
 
Good Aseptic Practices ppt
Good Aseptic Practices  pptGood Aseptic Practices  ppt
Good Aseptic Practices pptPharmaceutical
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processingRiyaRYadav
 

La actualidad más candente (20)

Qualification of Tablet Compression Machine.pptx
Qualification of Tablet Compression Machine.pptxQualification of Tablet Compression Machine.pptx
Qualification of Tablet Compression Machine.pptx
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validation
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technology
 
Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.
 
Process automation with respect to Sterile Products
Process automation with respect to Sterile ProductsProcess automation with respect to Sterile Products
Process automation with respect to Sterile Products
 
Manufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule mManufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule m
 
Sterile Facilities
Sterile FacilitiesSterile Facilities
Sterile Facilities
 
USP <1116> and its impact on Microbiology
USP <1116> and its impact on MicrobiologyUSP <1116> and its impact on Microbiology
USP <1116> and its impact on Microbiology
 
Environmental monitoring - viable particle sampling
Environmental monitoring - viable particle samplingEnvironmental monitoring - viable particle sampling
Environmental monitoring - viable particle sampling
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operation
 
STERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATIONSTERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATION
 
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC  Systems for Non Sterile PharmaceuticalsWHO Guidance on HVAC  Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
 
Aseptic process tech & advanced sterile product mfg rashmi nasare
Aseptic process tech & advanced sterile product mfg  rashmi nasareAseptic process tech & advanced sterile product mfg  rashmi nasare
Aseptic process tech & advanced sterile product mfg rashmi nasare
 
Improved Tablet Production.pptx
Improved Tablet Production.pptxImproved Tablet Production.pptx
Improved Tablet Production.pptx
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
cGMP's for sterile products
cGMP's  for sterile productscGMP's  for sterile products
cGMP's for sterile products
 
cleaning validation for SSP.pptx
cleaning validation for SSP.pptxcleaning validation for SSP.pptx
cleaning validation for SSP.pptx
 
Good Aseptic Practices ppt
Good Aseptic Practices  pptGood Aseptic Practices  ppt
Good Aseptic Practices ppt
 
Aseptic Process Technology.pptx
Aseptic Process Technology.pptxAseptic Process Technology.pptx
Aseptic Process Technology.pptx
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 

Similar a Microbial Contamination Control in Parenteral Manufacturing

cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxzohaibmaqsoodneutrop
 
Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Comecer
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxdrsriram2001
 
Cleaning validation presentation(1)
Cleaning validation presentation(1)Cleaning validation presentation(1)
Cleaning validation presentation(1)Randheer Dubey
 
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGN
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGNQUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGN
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGNsiddy-07
 
STERILE AND BULK MANUFACTURING. final.pptx
STERILE AND BULK MANUFACTURING. final.pptxSTERILE AND BULK MANUFACTURING. final.pptx
STERILE AND BULK MANUFACTURING. final.pptxPartha70
 
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical productsTrs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical productsQC at MinhDan Pharmaceutical
 
Application of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalApplication of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalFarzana Sultana
 
Manufacturing of sterile preparations
Manufacturing of sterile preparationsManufacturing of sterile preparations
Manufacturing of sterile preparationsShruti Tyagi
 
Parenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsParenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsAffrin Shaik
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Merck Life Sciences
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process? MilliporeSigma
 
Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...Ms. Pooja Bhandare
 
Manufacturing Bulk and Sterile
Manufacturing Bulk and SterileManufacturing Bulk and Sterile
Manufacturing Bulk and SterileRiazulHasan3
 
Manufacturing bulk and sterile
Manufacturing bulk and sterileManufacturing bulk and sterile
Manufacturing bulk and sterileRiazulHasan3
 
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANINGCONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANINGShankar Maind Patil
 

Similar a Microbial Contamination Control in Parenteral Manufacturing (20)

cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptx
 
Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptx
 
opthalmics.pptx
opthalmics.pptxopthalmics.pptx
opthalmics.pptx
 
Cleaning validation presentation(1)
Cleaning validation presentation(1)Cleaning validation presentation(1)
Cleaning validation presentation(1)
 
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGN
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGNQUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGN
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGN
 
STERILE AND BULK MANUFACTURING. final.pptx
STERILE AND BULK MANUFACTURING. final.pptxSTERILE AND BULK MANUFACTURING. final.pptx
STERILE AND BULK MANUFACTURING. final.pptx
 
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical productsTrs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
 
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical productsTRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
 
Application of filtration process in pharmaceutical
Application of filtration process in pharmaceuticalApplication of filtration process in pharmaceutical
Application of filtration process in pharmaceutical
 
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùngPhụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
 
Manufacturing of sterile preparations
Manufacturing of sterile preparationsManufacturing of sterile preparations
Manufacturing of sterile preparations
 
Parenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsParenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceutics
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...
 
STERILE Prpn.pptx
STERILE Prpn.pptxSTERILE Prpn.pptx
STERILE Prpn.pptx
 
Manufacturing Bulk and Sterile
Manufacturing Bulk and SterileManufacturing Bulk and Sterile
Manufacturing Bulk and Sterile
 
Manufacturing bulk and sterile
Manufacturing bulk and sterileManufacturing bulk and sterile
Manufacturing bulk and sterile
 
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANINGCONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
 

Último

Healthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterHealthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterJamesConcepcion7
 
Jewish Resources in the Family Resource Centre
Jewish Resources in the Family Resource CentreJewish Resources in the Family Resource Centre
Jewish Resources in the Family Resource CentreNZSG
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdfMintel Group
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Anamaria Contreras
 
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...SOFTTECHHUB
 
BAILMENT & PLEDGE business law notes.pptx
BAILMENT & PLEDGE business law notes.pptxBAILMENT & PLEDGE business law notes.pptx
BAILMENT & PLEDGE business law notes.pptxran17april2001
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryWhittensFineJewelry1
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxappkodes
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFChandresh Chudasama
 
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Associazione Digital Days
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSendBig4
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesDoe Paoro
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdfChris Skinner
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfDanny Diep To
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024Adnet Communications
 
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...ssuserf63bd7
 

Último (20)

Healthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterHealthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare Newsletter
 
Jewish Resources in the Family Resource Centre
Jewish Resources in the Family Resource CentreJewish Resources in the Family Resource Centre
Jewish Resources in the Family Resource Centre
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.
 
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...
How To Simplify Your Scheduling with AI Calendarfly The Hassle-Free Online Bo...
 
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptxThe Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
 
BAILMENT & PLEDGE business law notes.pptx
BAILMENT & PLEDGE business law notes.pptxBAILMENT & PLEDGE business law notes.pptx
BAILMENT & PLEDGE business law notes.pptx
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
 
WAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdfWAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdf
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptx
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDF
 
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.com
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic Experiences
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024
 
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
 

Microbial Contamination Control in Parenteral Manufacturing

  • 1. Microbial Contamination Control in Parenteral Manufacturing Pragati Kumar Bada pragatk@yahoo.com
  • 2. •Parenteral products are radically different from other dosage forms in terms of standards of purity and safety. •Apart from complying with standards of potency and stability, parenterals have to meet exacting standards of microbial (sterility and pyrogens), physical (particulate matter), and chemical (isotonicity, buffering capacity, etc.) parameters.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Various layers of protection in a typical Parenteral manufacturing
  • 8. Terminal Sterilization • In 1991 USFDA proposed that all sterile products should be terminally sterilized, unless data were available to prove its adverse effects on product stability . This was primarily due to the fact that all product recalls during 1981 to 1991 involved aseptically processed products . • Certain drug classes, such as biologics, multidose ophthalmic products, and dispersed systems, are exempt from this. • The most commonly used technique for terminal sterilization is autoclaving, which makes use of saturated steam. • Compendial cycles for autoclaving in USP/EP/BP prescribe a 15-minute exposure at 121°C.
  • 9. The most heat resistant microorganism actually contaminating the formulation—or Bacillus stearothermophillus because of its high heat resistance—is used as a standard microbe for development of autoclaving cycles. New Techniques of Terminal Sterilization: There is a strong need to develop terminal sterilization techniques that can help in achieving acceptable Sterility assurance level without causing damage to the product.
  • 10. • PurePulse® Technologies USA has developed a technique called Pure Bright sterilization. • It uses broad-spectrum pulsed light (BSPL) to effectively inactivate bacterial organisms and spores in static and flowing solutions, as well as on dry surfaces. • BSPL generated from xenon lamps contain visible, infrared, and UV wavelengths in ratios similar to sunlight. • The major difference from sunlight is that the UV wavelengths are removed due to filtration by Earth’s atmosphere. • Rapid intense pulses of BSPL are used for inactivation of pathogens.
  • 11. ASEPTIC PROCESSING • Aseptic processing involves filling of pre-sterilized formulations into cleaned and pre-sterilized primary packaging components. • In absence of any post-filling sterilization step, the SAL of finished product is a direct function of SAL of individual components. • Many aseptically manufactured presentations, especially multi dose products, contain preservatives that serve a dual purpose of (a) providing antimicrobial activity and (b) preventing proliferation of any microbe that might contaminate the product during repeated use. • Sterility assurance levels for aseptic processing is determined by performing media fill trials
  • 12. Sources of Contamination and Control Strategy During Aseptic Manufacture Contributing parameter Control strategy Environmental air Passing air supply through High Efficiency Particle Air (HEPA) filters. Laminar air flow (90 feet/min) is used to ―sweep away‖ particles and microbes from the sensitive areas. Environmental air Pressure differentials to protect areas of critical operations.
  • 13. Contributing parameter Control strategy Manufacturing • For fixed equipment Vacuum cleaner equipped with HEPA equipment filtered exhaust. • Wet wiping with disinfectant solution for Manufacturing equipment. • For demountable equipments cleaning and autoclaving should be performed.
  • 14. Contributing parameter Control strategy Formulation and • Powders for injection are primary packaging supplied as sterile by bulk components drug manufacturers. • Liquid products are filtered through sterile 0.22 μm membrane filters. • Glass vials are cleaned and dry heat sterilized Rubber stoppers are cleaned and sterilized by autoclaving.
  • 15. Contributing Control strategy parameter Personnel • Medical examination to screen personnel working in aseptic area. • Entry of personnel to aseptic area should be through changing rooms. • Containment of personnel microbial flora by protective clothing. • Localized barriers between personnel and areas of filling operations, by means of laminar airflow or by using isolator barriers.
  • 16. Contributing Control strategy parameter Water and Purification of water by distillation drainage or reverse osmosis. Storage of WFI at temperatures >80°C and in vessels fitted with continuous circulation loop. Efficient drainage at the manufacturing shop floor to prevent accumulation of water.
  • 17. Blow-Fill-Seal Technology (BFS) BFS technology involves a fully automated process in which the primary container for the formulation is (a)formed from a thermoplastic. (b)Aseptically filled with filtered solution (c)sealed, in a single operation in a controlled environment. • BFS uses an automated process requiring minimal human intervention once the machine settings have been set. • The formed plastic container is filled with sterile product and instantly sealed, thus avoiding contamination. • A hermetically sealed bottle formed during the process helps avoid the use of sealing devices like rubber closures and seals.
  • 19. • Various thermoplastics like polyethylene (PE), polypropylene (PP), various copolymers and polyalomers are commercially available. • PP offers distinct advantages by allowing exposure to 121°C for autoclaving. Bottles produced on the BFS machine can be individual or strip-dose formats, in sizes from 0.1 ml to 2000 ml, and outputs as high as 30,000 units/hour can be achieved. • BFS technology has offered a cost-effective means of Microbial contamination control introducing high-quality aseptically processed products with additional advantage of reduced breakage, reduced hazard of accidental injury, and reduced pack volume over glass containers.
  • 20. RECENT ISSUES IN STERILIZATION BY FILTRATION • Sterilization by filtration has traditionally involved use of 0.2/0.22 μm rated filters and Pseudomonas diminuta (now called Brevundimonas diminuta) as the standard challenge organism. • USFDA defines minimum qualifying area of 107/cm2 of filter area. • Stressful conditions may affect the changes in the morphology of the microbes. • In this study,40% reduction in size of Burkholderia pickettii was observed. • These developments are causing a shift from 0.2/0.22 rated filters to 0.1micron filters.
  • 21. STERILE PREFILLED SYRINGES (PFS) • PFS have become a popular packaging system for parenteral products due to their advantages of ease of administration, dosing accuracy, and increased assurance of sterility. PFS consists of a barrel, a plunger rod with rubber fitting, and a luer-lock tip/stainless steel needle. • The manufacturing process for PFS may involve (a) filling of formulation in previously cleaned and sterilized PFS or (b) cleaning, sterilization, de-pyrogenation of non sterile syringes, followed by filling . • The filling is carried out in Class 100 area, and other operations can be carried out in Class 10,000/100,000 area. • Terminal sterilization of PFS by autoclaving poses a unique challenge due to the possibility of rubber plunger migration during the process. This ―pop-off‖ of rubber plunger can be prevented by using autoclaves with a counter-pressure feature.
  • 22. PROCESS VALIDATION, HAZARD ANALYSIS AND CRITICAL CONTROL POINTS (HACCP) HACCP involves seven principles: (a)analyzing each step for hazard. (b)Identifying all critical control points (CCP). (c)verifying the limit for each CCP. (d) verifying monitoring and testing of limits. (e)verifying corrective actions. (f)verifying operational procedures for CCPs, and (g)verifying that records of each CCP are documented in the batch record.
  • 23. Critical Control Points in a Typical Parenteral Product Manufacturing
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. Test Organism The selection of a biological indicator appropriate for use with a particular sterilization process requires the consideration of a number of factors. First is identification of the appropriate test organism. The test organisms indicated in Table 1 are generally recognized to exhibit greater resistance to the indicated sterilization processes than typical bioburden.
  • 29. An example of different biological indicator formats, including spore suspensions, inoculated carriers, paper strip biological indicators, and self-contained biological indicators.
  • 30. Suspensions and Inoculated Carriers : Aliquots of the test organism are either inoculated directly onto product or onto suitable carriers that are then placed in those locations of the product considered to be the most difficult to sterilize. Following sterilization processing the number of surviving test organisms is determined by either direct transfer to growth medium (fraction-negative analysis) or removal of the test organisms from the product or carrier for direct enumeration. Paper Strip Biological Indicators : This type of biological indicator, consisting of a paper strip carrier inoculated with a suspension of test organisms and packaged in a glassine or Tyvek outer envelope has seen little change since its commercialization during
  • 31. Self-Contained Biological Indicators : Self-contained biological indicators are widely used in many applications, as they do not require the user to aseptically transfer the inoculated carrier to growth medium. Self-contained biological indicators incorporate both the test organisms and the growth medium within the same unit and are typically of two distinct types. The simplest form of self-contained biological indicators consist of a hermetically sealed glass ampule or vial containing spores of Geobacillus stearothermophilus suspended in growth medium with a pH indicator dye. Following sterilization processing the ampule is incubated and growth of the test organisms detected as a change in the color of the
  • 33. PRE TREATMENTS OF WATER • The principal purification units of distillation, reverse osmosis, ion- exchange, and electrodeionization can purify at least some small quantity of water of any degree of contamination even without pretreatment. • The question is how much before the particular purification unit is fouled or possibly irreparably damaged. • Chlorine will rapidly and irreversibly degrade polyamide RO membranes. Chloride ions will cause the corrosion of stainless steels.
  • 34. Chlorination • As a first step, raw waters are commonly chlorinated to kill pathogenic microbes. Chlorine concentrations of 1 ppm effect a 97% kill of E. coli in 0.6 minutes at 5–25°C, and 0.5 ppm amounts have the same effect in 7 minues at 5°C. Salmonella and Cholera are killed by 3 ppm. • When chlorine contacts water it reacts to form hypochlorous acid. HOCl dissociates to yield hydrogen ions, H+ (or hydronium ions, H3O+), and hypochlorous ions, OCl−. The sum of the hypochlorous acid and the hypochlorite ions is called the ―free available chlorine.‖ Hypochlorous acid is about 100 times stronger in its oxidizing potential than is the hypochlorite ion.
  • 35. chlorine partakes oxidatively in a free radical chain reaction with TOC present in the water to form the carcinogenic trihalomethanes (THM). REMOVAL OF THM The trihalomethanes found in feed waters consist of mixtures of chlorine and bromine atoms substituent on the single carbons created by the free radical chain scission reaction of chlorine on longer carbon-to-carbon TOC chains. Monobromo, dichloromethane Br-CH-Cl2; monochloro, dibromomethane Cl-CH-Br2; bromoform HC- Br3; and chloroform HC-Cl3 constitute the trihalomethanes. The THMs, except for chloroform, are destroyed to an 85% extent by 185 nm UV.
  • 36. They are removed by reaction with anion exchange resin in hydroxyl form; chloroform only to the extent of 50%. They are adsorbed by activated carbon in proportion to the surface area of the carbon and increasingly with bromine content; chloroform CHCl3 10%, bromoform CHBr3 50%.
  • 37. Deep Beds and Multimedia Filtration • Multimedia bed design is versatile, but there is no ready way to match its available constructions to the TSS, to the total suspended solids contents of given waters. • Particles too small in size to be retained even by the (bottom) most finely ground, densest medium bed may be present, as also colloidal particles. • Coagulation and flocculation techniques are then invoked to agglomerate the ultrafine particles to sizes that can be removed by the deep beds.
  • 38. Cross sections of representative filter particle gradations. Diagram (a) represents a single medium bed such as a rapid sand filter. The bottom half of a filter of this type does little or no work. Diagram (b) represents an ideal filter uniformly graded from coarse to fine from top to bottom. Diagram (c) represents a dual media bed, with coarse coal above fine sand, which approaches the goal of the ideal filter.
  • 39. Softening and Solubility Product Water softening is usually accomplished by way of sodium-form ion-exchange wherein the ion- exchange resin in the softening unit removes the hardness-causing elements from the feed waters by exchanging them for the sodium ions it releases. This fore-stalls subsequent mineral fouling of the RO by membrane-blocking deposits of alkaline earth salts of limited solubilities, such as the sulfates, carbonates, and fluorides of calcium, barium, or strontium.
  • 40. The solubility product of a salt is the maximum product of its cation and anion concentration expressed in moles per liter that can exist in equilibrium with its undissolved phase at any one temperature.